搜索临床试验以:乳清
总计601个结果
-
Eli Lilly and Company完全的
-
AstraZeneca完全的
-
Celgene Corporation完全的
-
Eli Lilly and Company完全的
-
Colorado State University完全的
-
Eli Lilly and Company完全的非小细胞肺癌美国, 法国, 意大利, 大韩民国, 德国, 葡萄牙
-
University of LeedsCelgene Corporation; Oncolytics Biotech; Myeloma UK未知
-
Eli Lilly and Company完全的
-
The Lymphoma Academic Research Organisation完全的滤泡性淋巴瘤患者(IB 期) | 滤泡性和侵袭性 (DLBCL&MCL) B 细胞淋巴瘤患者(II 期)法国, 比利时
-
Eli Lilly and Company终止
-
Opal Rheumatology Ltd.Merck Sharp & Dohme LLC未知
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)完全的
-
Bnai Zion Medical Center完全的
-
Celgene CorporationICON Clinical Research完全的
-
Eli Lilly and Company完全的
-
Aptium Oncology Research NetworkMillennium Pharmaceuticals, Inc.未知
-
Henry M. Jackson Foundation for the Advancement...Fort Belvoir Community Hospital完全的
-
Sun Yat-sen University未知
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital 和其他合作者终止
-
Institut Paoli-Calmettes完全的Acute Myeloid Leukemia or Myelodysplasic Syndrome法国
-
London School of Hygiene and Tropical MedicineNational Malaria Control Program, Ministry of Health and Sanitation; Pharmacy Board of Sierra...完全的
-
Georgetown UniversityEli Lilly and Company终止
-
Sun Yat-sen University招聘中
-
AIO-Studien-gGmbHBoehringer Ingelheim终止
-
The Lymphoma Academic Research Organisation招聘中
-
Oslo University HospitalHelse Stavanger HF; St. Olavs Hospital; Nordic Myeloma Study Group主动,不招人
-
University of PittsburghBristol-Myers Squibb; Eli Lilly and Company完全的
-
Eli Lilly and Company完全的非鳞状组织学的局部晚期或转移性 NSCLC 的组织学或细胞学诊断,且不适合治愈性治疗。匈牙利, 德国, 奥地利, 西班牙, 瑞典
-
Eli Lilly and Company完全的
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Genentech, Inc.; Brigham and Women's Hospital; Celgene Corporation终止